ACM
NUVA

Advent Capital Management’s NuVasive, Inc. NUVA Stock Holding History

Advent Capital Management’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-268
Closed -$12K – 265
2022
Q3 		$12K Buy
+268
New +$13K ﹤0.01% 221

Other funds holding NUVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Thrivent Financial for Lutherans
Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
CCM
Channing Capital Management Chicago, Illinois $4.34B AUM 37.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Advent Capital Management's NUVA Position: Q4 2022 in Review

Advent Capital Management sold out of NuVasive, Inc. (NUVA) in Q4 2022, closing a stake of 268 shares — an estimated $12K sold.

Advent Capital Management first reported a position in NUVA in Q3 2022 and held it in 1 quarter. The position peaked at $12K in Q3 2022. 235 funds tracked by Wall St. Rank hold NUVA as of Q4 2022.

  • Advent Capital Management reported no remaining NuVasive, Inc. position as of Q4 2022 after selling out during the quarter.
  • Advent Capital Management sold 268 NuVasive, Inc. shares in Q4 2022, an estimated $12K.
  • Advent Capital Management first reported a position in NuVasive, Inc. in Q3 2022 and held it in 1 quarter.
  • Advent Capital Management's NuVasive, Inc. position peaked at $12K in Q3 2022.
  • 235 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q4 2022.

Based on Advent Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.